| abstract |
A method for treating the human or non-human animal body is disclosed for the treatment of NO-dependent microcirculation disorders, for example microcirculation disorders, which are caused by metabolic disorders, such as, for. B. Increased levels of homocystine-homocysteine, inflammatory reactions or autoimmune diseases, as well as peripheral microcirculation disorders or microcirculation disorders associated with increased cell fragmentation, which method include that a human or non-human animal body in need of such treatment is effective Amount of a pharmaceutical composition containing a substance that scavenges free radicals, e.g. B. a pyrimidopyrimidine selected from dipyrimidamole, mopidamol and the pharmaceutically acceptable salts thereof is administered, and the use of such a substance for the preparation of a corresponding pharmaceutical composition, optionally in combination with an agent capable of increasing NO production is. |